Emcure Pharmaceuticals Ltd., a leading Indian pharmaceutical company, along with its subsidiary Gennova Biopharmaceuticals Limited, has signed a significant 22.78 MWp DC Solar Power Purchase Agreement (PPA) with Sunsure Energy, a major player in India’s renewable energy sector. This new agreement will provide Emcure and Gennova with approximately 36 million units of clean, renewable energy annually for their manufacturing facilities in Pune.
The PPA is set to meet around 67% of the power needs for these plants with green energy and will help offset approximately 29,765.71 metric tons of CO2 emissions each year. This move marks a substantial advance in Emcure’s commitment to sustainability.
As part of the agreement, Emcure and Gennova will also enter into a Shareholders Agreement to acquire a stake in Sunsure Solarpark Twelve Private Limited, facilitating their solar power purchase under a group captive scheme in accordance with the Electricity Act, 2023 and related regulations.
Sunsure Energy will supply the power from its 150 MWp DC solar plant located in Solapur, Maharashtra. This agreement strengthens Emcure’s dedication to sustainability by integrating renewable energy into its operations and reducing its environmental impact.
Mr. Sunil Mehta, Whole-time Director of Emcure Pharmaceuticals, commented, “At Emcure, we are committed to not only advancing healthcare through innovation but also enhancing our environmental practices. Our partnership with Sunsure Energy highlights our dedication to reducing the pharmaceutical industry’s carbon footprint through renewable energy solutions. We are proud to be at the forefront of solar power adoption in the pharmaceutical sector and look forward to further achievements in our green energy journey.”
Mr. Shashank Sharma, Founder and CEO of Sunsure Energy, expressed his enthusiasm, stating, “We are excited to welcome Emcure Pharmaceuticals into our network of esteemed clients. This PPA is a testament to Sunsure’s commitment to supporting major corporations in their renewable energy transition. By powering Emcure’s facilities with clean energy, we are contributing to broader environmental stewardship within the pharmaceutical industry.”
Emcure Pharmaceuticals is renowned for its commitment to environmental sustainability, implementing green initiatives and eco-friendly practices across its operations. The company adheres to stringent good manufacturing practices (cGMP) and international regulatory standards, and its facilities are equipped with energy-efficient systems, advanced waste management and pollution control measures, and rainwater harvesting systems. Emcure’s R&D efforts also focus on solvent recycling and recovery, and its manufacturing plants feature Zero Liquid Discharge systems and Effluent Treatment Plants, ensuring the treatment of 100% of waste generated. This dedication underscores Emcure’s role in promoting sustainable development and environmental protection.
Discover more from SolarQuarter
Subscribe to get the latest posts sent to your email.
